what are the fda approved glp 1 drugs approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic US FDA accepts Novo Nordisk's
Description
Slower Titration Often Makes Sense GI side effects like nausea, vomiting, and diarrhea are the most common reason patients reduce their dose or discontinue GLP-1 therapy

Allergic reaction Some people may have an allergic reaction to Farxiga

If you stop taking Ozempic, there is a possibility that you may regain weight

With increasing concern over adverse events across the class, liver safety, cardiovascular outcomes, PK and PD stability, and dose optimized adherence will decide which assets rise to best in class status
Some studies have shown a reduction in major adverse cardiovascular events by 18-20%

2024;386:q1645
